Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

59.02
-0.6200-1.04%
Volume:536.06K
Turnover:31.85M
Market Cap:11.32B
PE:21.82
High:60.16
Open:59.96
Low:58.86
Close:59.64
Loading ...

Stock Track | BioMarin Pharmaceutical Stock Soars 7.83% After-Hours on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
·
20 Feb

BioMarin: Q4 Earnings Snapshot

Associated Press Finance
·
20 Feb

BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars

StockStory
·
20 Feb

BioMarin Pharmaceutical Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set -- Shares Up After Hours

MT Newswires Live
·
20 Feb

Biomarin Pharmaceutical Q4 Adj $0.92 Beats $0.53 Estimate, Sales $747.31M Beat $713.44M Estimate

Benzinga
·
20 Feb

BRIEF-Biomarin Pharmaceutical Q4 EPS USD 0.64

Reuters
·
20 Feb

Biomarin Pharmaceutical- in 2025, FY Total Revenues Guidance Represents 10% Y/Y Growth at Mid-Point

THOMSON REUTERS
·
20 Feb

Biomarin Pharmaceutical Inc - 2025 Non-Gaap Diluted EPS Expected to Increase 22% Y/Y at Mid-Point

THOMSON REUTERS
·
20 Feb

Biomarin Pharmaceutical- Ongoing Integration of Efficiencies in 2025 Expected to Enable Co to Realize 40% Non-Gaap Operating Margin in 2026

THOMSON REUTERS
·
20 Feb

Biomarin Pharmaceutical Q4 Basic EPS USD 0.66

THOMSON REUTERS
·
20 Feb

BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance

PR Newswire
·
20 Feb

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

StockStory
·
18 Feb

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks
·
17 Feb

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Zacks
·
17 Feb

BioMarin to Report Q4 Earnings: Here's What to Expect

Zacks
·
17 Feb

Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?

Benzinga
·
14 Feb

SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
13 Feb

Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics

Zacks
·
13 Feb

BMRN vs. CSLLY: Which Stock Is the Better Value Option?

Zacks
·
13 Feb

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks
·
12 Feb